glp 1 pill fda approved approves Wegovy weight-loss GLP-1 With FDA approval of Wegovy

Analyses were conducted in April 2026 and include data from 141 Noom GLP-1Rx Program members who started a GLP-1Rx plan in NovemberDecember 2025 (Sample 1) and 51 Noom GLP-1Rx Program members who started between November 2024 and June 2025 (Sample 2) and responded to a follow-up survey after discontinuation

Benefits Effective Weight Loss: Clinical trials have demonstrated that GLP-1 agonists can lead to significant weight loss, especially in individuals with obesity or overweight conditions

Dimitriadis, F., Tsambalas, S., Tsounapi, P., Kawamura, H., Vlachopoulou, E., Haliasos, N., Gratsias, S., Watanabe, T., Saito, M., Miyagawa, I., and Sofikitis, N

It should be noted that we do not include mitochondrial glutathione, which the Jaeschke group has found to be fundamental in APAP pathophysiology [36]